Genomtec S.A. (GMT.WA) — Stock Score Summary

Genomtec S.A. (GMT.WA) has a MoatMap StockRank of 14/100 based on Quality (19/100), Value (31/100), and Momentum (48/100) factor scores. The current signal is STRONG SELL. Genomtec is a micro-cap molecular diagnostics company with highly speculative cash flows and no established market share. It fails the Terry Smith quality compounder test and lacks the scale to survive intense competition in the medtech space.

Genomtec S.A. is a Polish medical technology company specializing in the development of innovative mobile molecular diagnostics platforms for point-of-care testing (POCT). The company's flagship technology, Genomtec ID, utilizes proprietary isothermal amplification (SNAAT) and microfluidic chips to deliver rapid, laboratory-grade genetic analysis in minutes. It positions itself as a high-tech innovator aiming to disrupt the global diagnostics market with decentralized, affordable testing solutions.

Key Financial Metrics

Price$1.35
Market Cap$21M
Price/Book10.48
Return on Equity-111.0%
Return on Invested Capital-95.6%
Debt/Equity20.18
Gross Margin0.0%
Operating Margin-13387.5%
Revenue Growth220.0%
Free Cash Flow$-331K

Genomtec S.A. operates in the Medical Devices industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is Genomtec S.A.’s (GMT.WA) StockRank?
MoatMap’s StockRank for Genomtec S.A. (GMT.WA) is 14/100, with a Strong Sell signal. It is a composite of Quality (19), Value (31), and Momentum (48) factor ranks across MoatMap’s 19,000+ stock universe.
Does Genomtec S.A. have an economic moat?
Genomtec S.A. (GMT.WA) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Genomtec S.A. a buy, hold, or sell?
MoatMap’s current signal for Genomtec S.A. (GMT.WA) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Genomtec S.A. in?
Genomtec S.A. (GMT.WA) operates in the Healthcare sector, specifically the Medical Devices industry (Poland).
Browse all ranked stocksGMT.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock